Strategic Role and Objectives:
In his new role, Dr. Sanchez-Gonzalez will spearhead the development, management, and execution of comprehensive education, communication and business development strategies aimed at clinicians and providers. His responsibilities include enhancing provider relationships and supporting the clinical applications of our cutting-edge technologies, products, and services. Dr. Sanchez-Gonzalez will also lead the creation and implementation of key educational events, directly and through our growing medical practice networks.
Principal Duties and Responsibilities:
- Educational Support and Training: Dr. Sanchez-Gonzalez will support our sales efforts, providing scientific expertise to customers and potential customers. He will play a critical role in educating clinicians, staff, and partners about our technologies.
- Training and Relationship Management: He will manage and execute training for in-house personnel, field staff, and alliance partners on key technologies and clinical applications, while also managing vital clinician-provider relationships.
- Collaboration and Development: Dr. Sanchez-Gonzalez will work closely with our Marketing, Operations and Software Development teams to identify opportunities that promote the utilization of our products and support our corporate strategies.
- Post-market Clinical Evaluation: He will establish and manage a post-market clinical evaluation portfolio, which includes, data analysis, literature and case studies aligned with our corporate needs.
- Conference Participation: Dr. Sanchez-Gonzalez will attend and present at industry conferences and meetings, serving as a technical and medical expert on key technologies.
Role as a Medical Science Liaison:
Dr. Sanchez-Gonzalez will leverage his credentials to forge partnerships with target medical organizations, enhancing service delivery and integrating clinical insights into QHSLab’s operational framework. His focus on making our services clinically relevant and efficiently delivered will support QHSLab’s mission to improve patient outcomes and enhance the quality of healthcare.
Executive Commentary:
For more information about
About
Forward-Looking Statements
Certain matters discussed in this press release are ‘forward-looking statements’ intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company’s statements regarding trends in the marketplace, future revenues, future products, and potential future results and acquisitions are examples of such forward-looking statements. Forward-looking statements are generally identified by words such as ‘may,’ ‘could,’ ‘believes,’ ‘estimates,’ ‘targets,’ ‘expects,’ or ‘intends,’ and other similar words that express risks and uncertainties. These statements are subject to numerous risks and uncertainties, including, but not limited to, the timing of the introduction of new products, the inherent discrepancy in actual results from estimates, projections, and forecasts made by management, regulatory delays, changes in government funding and budgets, and other factors, including general economic conditions, not within the Company’s control. The factors discussed herein and expressed from time to time in the Company’s filings with the
Investor Relations Contact:
(929) 379-6503
ir@usaqcorp.com
https://twitter.com/QHSLabInc
Source:
2024 GlobeNewswire, Inc., source